-
1
-
-
0027370108
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
-
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
-
(1993)
N Engl J Med
, vol.329
, pp. 977-986
-
-
-
2
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
3
-
-
33645732339
-
Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications
-
Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 2006;295:1707-8.
-
(2006)
JAMA
, vol.295
, pp. 1707-1708
-
-
Brownlee, M.1
Hirsch, I.B.2
-
4
-
-
13844262952
-
The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with type 2 diabetes
-
Gallagher A, Home PD. The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with type 2 diabetes. Diabetes Res Clin Pract 2005;67:196-203.
-
(2005)
Diabetes Res Clin Pract
, vol.67
, pp. 196-203
-
-
Gallagher, A.1
Home, P.D.2
-
5
-
-
0033646935
-
Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level
-
Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000;23:1830-4.
-
(2000)
Diabetes Care
, vol.23
, pp. 1830-1834
-
-
Temelkova-Kurktschiev, T.S.1
Koehler, C.2
Henkel, E.3
Leonhardt, W.4
Fuecker, K.5
Hanefeld, M.6
-
6
-
-
77955677620
-
Glycemic variability in inadequately controlled type 1 diabetes and type 2 diabetes on intensive insulin therapy: a cross-sectional, observational study
-
Greven WL, Beulens JW, Biesma DH, Faiz S, de Valk HW. Glycemic variability in inadequately controlled type 1 diabetes and type 2 diabetes on intensive insulin therapy: a cross-sectional, observational study. Diabetes Technol Ther 2010;12:695-9.
-
(2010)
Diabetes Technol Ther
, vol.12
, pp. 695-699
-
-
Greven, W.L.1
Beulens, J.W.2
Biesma, D.H.3
Faiz, S.4
de Valk, H.W.5
-
7
-
-
34247871323
-
Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
-
UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007;50:1140-7.
-
(2007)
Diabetologia
, vol.50
, pp. 1140-1147
-
-
Hypoglycaemia Study Group, U.K.1
-
8
-
-
34447547886
-
Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin
-
Kudva YC, Basu A, Jenkins GD, Pons GM, Vogelsang DA, Riz za RA, Smith SA, Isley WL. Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin. Endocr Pract 2007;13:244-50.
-
(2007)
Endocr Pract
, vol.13
, pp. 244-250
-
-
Kudva, Y.C.1
Basu, A.2
Jenkins, G.D.3
Pons, G.M.4
Vogelsang, D.A.5
Rizza, R.A.6
Smith, S.A.7
Isley, W.L.8
-
9
-
-
84861980901
-
Increasing trend in the number of severe hypoglycemia patients in Korea
-
Kim JT, Oh TJ, Lee YA, Bae JH, Kim HJ, Jung HS, Cho YM, Park KS, Lim S, Jang HC, Lee HK. Increasing trend in the number of severe hypoglycemia patients in Korea. Diabetes Metab J 2011;35:166-72.
-
(2011)
Diabetes Metab J
, vol.35
, pp. 166-172
-
-
Kim, J.T.1
Oh, T.J.2
Lee, Y.A.3
Bae, J.H.4
Kim, H.J.5
Jung, H.S.6
Cho, Y.M.7
Park, K.S.8
Lim, S.9
Jang, H.C.10
Lee, H.K.11
-
10
-
-
67650649397
-
Reducing glycaemic variability in type 1 diabetes self-management with a continuous glucose monitoring system based on wired enzyme technology
-
Danne T, de Valk HW, Kracht T, Walte K, Geldmacher R, Solter L, von dem Berge W, Welsh ZK, Bugler JR, Lange K, Kordonouri O. Reducing glycaemic variability in type 1 diabetes self-management with a continuous glucose monitoring system based on wired enzyme technology. Diabetologia 2009;52:1496-503.
-
(2009)
Diabetologia
, vol.52
, pp. 1496-1503
-
-
Danne, T.1
de Valk, H.W.2
Kracht, T.3
Walte, K.4
Geldmacher, R.5
Solter, L.6
von dem Berge, W.7
Welsh, Z.K.8
Bugler, J.R.9
Lange, K.10
Kordonouri, O.11
-
11
-
-
33845342900
-
A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus
-
McCall AL, Cox DJ, Crean J, Gloster M, Kovatchev BP. A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus. Diabetes Technol Ther 2006;8:644-53.
-
(2006)
Diabetes Technol Ther
, vol.8
, pp. 644-653
-
-
McCall, A.L.1
Cox, D.J.2
Crean, J.3
Gloster, M.4
Kovatchev, B.P.5
-
12
-
-
0027984450
-
Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control
-
Yamanouchi T, Akanuma Y. Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control. Diabetes Res Clin Pract 1994;24 Suppl:S261-8.
-
(1994)
Diabetes Res Clin Pract
, vol.24
, pp. S261-S268
-
-
Yamanouchi, T.1
Akanuma, Y.2
-
13
-
-
0036021732
-
1,5-anhydro-D-glucitol: a novel marker of glucose excursions
-
Dworacka M, Winiarska H, Szymanska M, Kuczynski S, Szczawinska K, Wierusz-Wysocka B. 1,5-anhydro-D-glucitol: a novel marker of glucose excursions. Int J Clin Pract Suppl 2002;129:40-4.
-
(2002)
Int J Clin Pract
, vol.129
, pp. 40-44
-
-
Dworacka, M.1
Winiarska, H.2
Szymanska, M.3
Kuczynski, S.4
Szczawinska, K.5
Wierusz-Wysocka, B.6
-
14
-
-
38149030947
-
1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions
-
Dungan KM. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions. Expert Rev Mol Diagn 2008;8:9-19.
-
(2008)
Expert Rev Mol Diagn
, vol.8
, pp. 9-19
-
-
Dungan, K.M.1
-
15
-
-
62049085193
-
1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes
-
Won JC, Park CY, Park HS, Kim JH, Choi ES, Rhee EJ, Lee WY, Oh KW, Kim SW, Park SW. 1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes. Diabetes Res Clin Pract 2009;84:51-7.
-
(2009)
Diabetes Res Clin Pract
, vol.84
, pp. 51-57
-
-
Won, J.C.1
Park, C.Y.2
Park, H.S.3
Kim, J.H.4
Choi, E.S.5
Rhee, E.J.6
Lee, W.Y.7
Oh, K.W.8
Kim, S.W.9
Park, S.W.10
-
16
-
-
49649098029
-
Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients
-
Stettler C, Stahl M, Allemann S, Diem P, Schmidlin K, Zwahlen M, Riesen W, Keller U, Christ E. Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients. Diabetes Care 2008;31:1534-5.
-
(2008)
Diabetes Care
, vol.31
, pp. 1534-1535
-
-
Stettler, C.1
Stahl, M.2
Allemann, S.3
Diem, P.4
Schmidlin, K.5
Zwahlen, M.6
Riesen, W.7
Keller, U.8
Christ, E.9
-
17
-
-
17844376801
-
A novel approach to continuous glucose analysis utilizing glycemic variation
-
McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ. A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 2005;7:253-63.
-
(2005)
Diabetes Technol Ther
, vol.7
, pp. 253-263
-
-
McDonnell, C.M.1
Donath, S.M.2
Vidmar, S.I.3
Werther, G.A.4
Cameron, F.J.5
-
18
-
-
0014848738
-
Mean amplitude of glycemic excursions, a measure of diabetic instability
-
Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19:644-55.
-
(1970)
Diabetes
, vol.19
, pp. 644-655
-
-
Service, F.J.1
Molnar, G.D.2
Rosevear, J.W.3
Ackerman, E.4
Gatewood, L.C.5
Taylor, W.F.6
-
19
-
-
1842527586
-
Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation
-
Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, Shapiro AM, Vantyghem MC. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004;53:955-62.
-
(2004)
Diabetes
, vol.53
, pp. 955-962
-
-
Ryan, E.A.1
Shandro, T.2
Green, K.3
Paty, B.W.4
Senior, P.A.5
Bigam, D.6
Shapiro, A.M.7
Vantyghem, M.C.8
-
20
-
-
33746403773
-
1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes
-
Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care 2006;29:1214-9.
-
(2006)
Diabetes Care
, vol.29
, pp. 1214-1219
-
-
Dungan, K.M.1
Buse, J.B.2
Largay, J.3
Kelly, M.M.4
Button, E.A.5
Kato, S.6
Wittlin, S.7
-
21
-
-
0025056499
-
Blood glucose area under the curve. Methodological aspects
-
Le Floch JP, Escuyer P, Baudin E, Baudon D, Perlemuter L. Blood glucose area under the curve. Methodological aspects. Diabetes Care 1990;13:172-5.
-
(1990)
Diabetes Care
, vol.13
, pp. 172-175
-
-
Le Floch, J.P.1
Escuyer, P.2
Baudin, E.3
Baudon, D.4
Perlemuter, L.5
-
22
-
-
0037093012
-
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
-
Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002;287:2563-9.
-
(2002)
JAMA
, vol.287
, pp. 2563-2569
-
-
-
24
-
-
58849150951
-
A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial
-
Kilpatrick ES, Rigby AS, Atkin SL. A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care 2008;31:2198-202.
-
(2008)
Diabetes Care
, vol.31
, pp. 2198-2202
-
-
Kilpatrick, E.S.1
Rigby, A.S.2
Atkin, S.L.3
-
25
-
-
65649093012
-
Glycemic risk factors of diabetic vascular complications: the role of glycemic variability
-
Zaccardi F, Pitocco D, Ghirlanda G. Glycemic risk factors of diabetic vascular complications: the role of glycemic variability. Diabetes Metab Res Rev 2009;25:199-207.
-
(2009)
Diabetes Metab Res Rev
, vol.25
, pp. 199-207
-
-
Zaccardi, F.1
Pitocco, D.2
Ghirlanda, G.3
-
26
-
-
0242300561
-
Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation
-
Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003;52:2795-804.
-
(2003)
Diabetes
, vol.52
, pp. 2795-2804
-
-
Quagliaro, L.1
Piconi, L.2
Assaloni, R.3
Martinelli, L.4
Motz, E.5
Ceriello, A.6
-
27
-
-
0029957413
-
Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up
-
Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996;39:1577-83.
-
(1996)
Diabetologia
, vol.39
, pp. 1577-1583
-
-
Hanefeld, M.1
Fischer, S.2
Julius, U.3
Schulze, J.4
Schwanebeck, U.5
Schmechel, H.6
Ziegelasch, H.J.7
Lindner, J.8
-
28
-
-
84869038405
-
Severe hypoglycemia is a serious complication and becoming an economic burden in diabetes
-
Ha WC, Oh SJ, Kim JH, Lee JM, Chang SA, Sohn TS, Son HS. Severe hypoglycemia is a serious complication and becoming an economic burden in diabetes. Diabetes Metab J 2012;36:280-4.
-
(2012)
Diabetes Metab J
, vol.36
, pp. 280-284
-
-
Ha, W.C.1
Oh, S.J.2
Kim, J.H.3
Lee, J.M.4
Chang, S.A.5
Sohn, T.S.6
Son, H.S.7
|